BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10362320)

  • 1. Detection of hypoxic cells with the 2-nitroimidazole, EF5, correlates with early redox changes in rat brain after perinatal hypoxia-ischemia.
    Bergeron M; Evans SM; Sharp FR; Koch CJ; Lord EM; Ferriero DM
    Neuroscience; 1999; 89(4):1357-66. PubMed ID: 10362320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of individual hypoxic cells in multicellular spheroids by flow cytometry using the 2-nitroimidazole, EF5, and monoclonal antibodies.
    Woods ML; Koch CJ; Lord EM
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):93-101. PubMed ID: 12118570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts.
    Lee J; Siemann DW; Koch CJ; Lord EM
    Int J Cancer; 1996 Jul; 67(3):372-8. PubMed ID: 8707411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts.
    Lord EM; Harwell L; Koch CJ
    Cancer Res; 1993 Dec; 53(23):5721-6. PubMed ID: 8242628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors.
    Laughlin KM; Evans SM; Jenkins WT; Tracy M; Chan CY; Lord EM; Koch CJ
    J Pharmacol Exp Ther; 1996 May; 277(2):1049-57. PubMed ID: 8627516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5.
    Ziemer LS; Evans SM; Kachur AV; Shuman AL; Cardi CA; Jenkins WT; Karp JS; Alavi A; Dolbier WR; Koch CJ
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):259-66. PubMed ID: 12552344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondrocytes in the endochondral growth cartilage are not hypoxic.
    Shapiro IM; Mansfield KD; Evans SM; Lord EM; Koch CJ
    Am J Physiol; 1997 Apr; 272(4 Pt 1):C1134-43. PubMed ID: 9142837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperbaric oxygen reduces tissue hypoxia and hypoxia-inducible factor-1 alpha expression in focal cerebral ischemia.
    Sun L; Marti HH; Veltkamp R
    Stroke; 2008 Mar; 39(3):1000-6. PubMed ID: 18239183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-ischemia, but not hypoxia alone, induces the expression of heme oxygenase-1 (HSP32) in newborn rat brain.
    Bergeron M; Ferriero DM; Vreman HJ; Stevenson DK; Sharp FR
    J Cereb Blood Flow Metab; 1997 Jun; 17(6):647-58. PubMed ID: 9236721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical labelling of aerobic and hypoxic mammalian cells using a platinated derivative of EF5.
    Matthews J; Adomat H; Farrell N; King P; Koch C; Lord E; Palcic B; Poulin N; Sangulin J; Skov K
    Br J Cancer Suppl; 1996 Jul; 27():S200-3. PubMed ID: 8763880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ oxygen utilization in the rat intervertebral disc.
    Lee DC; Adams CS; Albert TJ; Shapiro IM; Evans SM; Koch CJ
    J Anat; 2007 Mar; 210(3):294-303. PubMed ID: 17331178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1.
    Chavez JC; LaManna JC
    J Neurosci; 2002 Oct; 22(20):8922-31. PubMed ID: 12388599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide].
    Evans SM; Joiner B; Jenkins WT; Laughlin KM; Lord EM; Koch CJ
    Br J Cancer; 1995 Oct; 72(4):875-82. PubMed ID: 7547234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode.
    Jenkins WT; Evans SM; Koch CJ
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):1005-17. PubMed ID: 10705024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of 19F MRS detection of the hypoxic cell marker EF5 to assess cellular hypoxia in solid tumors.
    Salmon HW; Siemann DW
    Radiother Oncol; 2004 Dec; 73(3):359-66. PubMed ID: 15588883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia in human intraperitoneal and extremity sarcomas.
    Evans SM; Hahn SM; Magarelli DP; Zhang PJ; Jenkins WT; Fraker DL; Hsi RA; McKenna WG; Koch CJ
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):587-96. PubMed ID: 11173159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo colocalization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors.
    Mahy P; De Bast M; Gallez B; Gueulette J; Koch CJ; Scalliet P; Grégoire V
    Radiother Oncol; 2003 Apr; 67(1):53-61. PubMed ID: 12758240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats.
    Kumral A; Yesilirmak DC; Sonmez U; Baskin H; Tugyan K; Yilmaz O; Genc S; Gokmen N; Genc K; Duman N; Ozkan H
    Brain Res; 2006 Oct; 1115(1):169-78. PubMed ID: 16938277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of hypoxia by [18F]EF5 in atherosclerotic plaques in mice.
    Silvola JM; Saraste A; Forsback S; Laine VJ; Saukko P; Heinonen SE; Ylä-Herttuala S; Roivainen A; Knuuti J
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1011-5. PubMed ID: 21372297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2-nitroimidazole EF5 is a biomarker for oxidoreductases that activate the bioreductive prodrug CEN-209 under hypoxia.
    Wang J; Foehrenbacher A; Su J; Patel R; Hay MP; Hicks KO; Wilson WR
    Clin Cancer Res; 2012 Mar; 18(6):1684-95. PubMed ID: 22167409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.